<DOC>
	<DOCNO>NCT00717834</DOCNO>
	<brief_summary>The primary objective study assess safety tolerability Ross River Virus ( RRV ) Vaccine healthy young adult population . Other objective study assess immunogenicity RRV Vaccine healthy young adult population identify optimal dose level RRV Vaccine healthy young adult population .</brief_summary>
	<brief_title>Safety Immunogenicity Study Ross River Virus ( RRV ) Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Formaldehyde</mesh_term>
	<criteria>Are 18 40 year age , inclusive , day screening ; Have understand study procedure , agree provision , give write informed consent prior study entry ; Are generally healthy ; Are physically mentally capable participate study follow study procedure ; Agree keep daily record symptom duration study ; If female childbearing potential negative urine pregnancy test result within 24 hour schedule first vaccination agree employ adequate birth control measure duration study . Have history RRV exposure history travel RRV endemic area : Australia , West Papua , Papua New Guinea , Solomon Islands , New Caledonia , Fiji Islands , Samoa Islands Cook Island ; Have Body Mass Index &gt; 35 ; Have elevate blood pressure screen &gt; 159 mmHg systolic and/or &gt; 99 mmHg diastolic seat rest confirm two additional measurement take least 30 minute apart ( seat rest ) ; Have clinically significant abnormal clinical laboratory value screen ; Have clinically significant electrocardiographic abnormality screen ; Test positive Human Immunodeficiency Virus ( HIV ) , Hepatitis B Surface Antigen ( HbsAg ) Hepatitis C Virus ( HCV ) ; Have history cardiovascular disease ; Have history immunodeficiency autoimmune disease ; Have history arthritis ( joint swelling , tenderness , warmth erythema ) one occasion , relate trauma ( include run ) episode nontrauma related arthritis within previous 6 month ; Have active neoplastic disease history hematological malignancy ; Have disease undergo form treatment expect influence immune response . Such treatment include , limited , systemic high dose inhale ( &gt; 800 mg/day beclomethasone dipropionate equivalent ) , corticosteroid , radiation treatment immunosuppressive cytotoxic drug ; Have history inflammatory degenerative neurological disease ( eg Guillain Barr√© , multiple sclerosis ) ; Have receive vaccination within 2 week prior vaccination study ; Have receive blood transfusion immunoglobulin within 30 day prior vaccination study ; Have donate blood plasma within 30 day prior vaccination study ; Have history vaccine relate contraindicate event ( eg , anaphylaxis , allergy component test vaccine , know contraindication ) ; Have rash , dermatologic condition tattoo may interfere injection site reaction rating ; Have positive urine drug screen , ( unless detect drug currently prescribe license health care provider continue administration drug would otherwise exclude subject participation ) ; Were administer investigational drug within 6 week prior study entry ; Are concurrently participate clinical study include administration investigational product ; Are member team conduct study ; Are dependent relationship one study team member . Dependent relationship include close relative ( ie , child , partner/spouse , sibling , parent ) well employee investigator site personnel conduct study ; If female , pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>